AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Stemmer SM

Stemmer SM

Tel Aviv University - Tel Aviv / Israel
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 411488
אוניברסיטת תל־אביב
person_outline Stemmer SM's MOST POPULAR ARTICLES
1-) Ribociclib as first-line therapy for HR-positive, advanced breast cancer New England journal of medicine 375 (18), 1738-1748, 2016
2-) Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation Journal of clinical oncology 33 (3), 244-250, 2015
3-) Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet 390 (10106), 1949-1961, 2017
4-) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases Annals of oncology 23 (5), 1341-1347, 2012
5-) Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced … Annals of Oncology 29 (7), 1541-1547, 2018